166 related articles for article (PubMed ID: 34406985)
1. Combination of radiotherapy and targeted therapy for melanoma brain metastases: a systematic review.
Ge Y; Che X; Gao X; Zhao S; Su J
Melanoma Res; 2021 Oct; 31(5):413-420. PubMed ID: 34406985
[TBL] [Abstract][Full Text] [Related]
2. The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis.
Rulli E; Legramandi L; Salvati L; Mandala M
Cancer; 2019 Nov; 125(21):3776-3789. PubMed ID: 31287564
[TBL] [Abstract][Full Text] [Related]
3. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule J; Kroeze SGC; Blanck O; Stera S; Kahl KH; Roeder F; Combs SE; Kaul D; Claes A; Schymalla MM; Adebahr S; Eckert F; Lohaus F; Abbasi-Senger N; Henke G; Szuecs M; Geier M; Sundahl N; Buergy D; Dummer R; Guckenberger M
Radiat Oncol; 2020 Jun; 15(1):135. PubMed ID: 32487100
[TBL] [Abstract][Full Text] [Related]
4. The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review.
van Opijnen MP; Dirven L; Coremans IEM; Taphoorn MJB; Kapiteijn EHW
Int J Cancer; 2020 Mar; 146(6):1479-1489. PubMed ID: 31583684
[TBL] [Abstract][Full Text] [Related]
5. Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis.
Petrelli F; De Stefani A; Trevisan F; Parati C; Inno A; Merelli B; Ghidini M; Bruschieri L; Vitali E; Cabiddu M; Borgonovo K; Ghilardi M; Barni S; Ghidini A
Crit Rev Oncol Hematol; 2019 Dec; 144():102830. PubMed ID: 31733443
[TBL] [Abstract][Full Text] [Related]
6. Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.
Trino E; Mantovani C; Badellino S; Ricardi U; Filippi AR
Expert Rev Anticancer Ther; 2017 Apr; 17(4):347-356. PubMed ID: 28277101
[TBL] [Abstract][Full Text] [Related]
7. The role of systemic therapies in the management of melanoma brain metastases.
Lyle M; Long GV
Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
[TBL] [Abstract][Full Text] [Related]
8. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-A retrospective cohort study.
Gatterbauer B; Hirschmann D; Eberherr N; Untersteiner H; Cho A; Shaltout A; Göbl P; Fitschek F; Dorfer C; Wolfsberger S; Kasprian G; Höller C; Frischer JM
Cancer Med; 2020 Jun; 9(11):4026-4036. PubMed ID: 32249551
[TBL] [Abstract][Full Text] [Related]
11. The changing paradigm of management in melanoma brain metastases.
Ladwa R; Atkinson V
Asia Pac J Clin Oncol; 2018 Dec; 14(6):453-458. PubMed ID: 29932306
[TBL] [Abstract][Full Text] [Related]
12. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
13. Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort.
Tétu P; Allayous C; Oriano B; Dalle S; Mortier L; Leccia MT; Guillot B; Dalac S; Dutriaux C; Lacour JP; Saiag P; Brunet-Possenti F; De Quatrebarbes J; Stoebner PE; Legoupil D; Beylot-Barry M; Lesimple T; Aubin F; Dreno B; Mohamed S; Ballon A; Porcher R; Lebbe C
Eur J Cancer; 2019 May; 112():38-46. PubMed ID: 30909072
[TBL] [Abstract][Full Text] [Related]
14. Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases.
Moyers JT; Chong EG; Peng J; Tsai HHC; Sufficool D; Shavlik D; Nagaraj G
Cancer Med; 2021 Feb; 10(4):1201-1211. PubMed ID: 33484100
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
17. The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.
Kaidar-Person O; Zagar TM; Deal A; Moschos SJ; Ewend MG; Sasaki-Adams D; Lee CB; Collichio FA; Fried D; Marks LB; Chera BS
Anticancer Drugs; 2017 Jul; 28(6):669-675. PubMed ID: 28368903
[TBL] [Abstract][Full Text] [Related]
18. Melanoma brain metastases: is it time to eliminate radiotherapy?
White RJ; Abel S; Horne ZD; Lee J; Edington H; Greenberg L; Younes H; Hilton C; Wegner RE
J Neurooncol; 2020 Aug; 149(1):27-33. PubMed ID: 32556863
[TBL] [Abstract][Full Text] [Related]
19. Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.
Galli G; Cavalieri S; Di Guardo L; Cimminiello C; Nichetti F; Corti F; Garcia MA; Pappalardi B; Fallai C; de Braud F; Platania M; Del Vecchio M
Oncol Res Treat; 2019; 42(4):186-194. PubMed ID: 30836373
[TBL] [Abstract][Full Text] [Related]
20. Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma.
Okwan-Duodu D; Pollack BP; Lawson D; Khan MK
Am J Clin Oncol; 2015 Feb; 38(1):119-25. PubMed ID: 23648438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
